Message #28 From:
Stock News Bot Date: November 1, 2005 08:00:00 AM
DBMI News DOBI Medical International to Present at the Rodman & Renshaw Techvest Healthcare Conference
MAHWAH, N.J.--(BUSINESS WIRE)--Nov. 1, 2005--DOBI Medical International, Inc. (DBMI.OB) will participate in the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 7-9 at The Palace Hotel in New York City. Robert Sohval, PhD, Vice President of Research and Development for DOBI Medical, will present a company update on the ComfortScan(R) system on Monday, November 7, at 12:20pm ET. DOBI Medical International is a New Jersey-based medical device imaging company developing light-based technologies designed to aid physicians in the diagnosis of breast disease.
Rodman & Renshaw, LLC is a privately-held, full-service investment bank committed to fostering the long-term success of emerging growth companies through capital raising, strategic advice, insightful research, and the development of institutional support. They have been serving the emerging growth sector market for more than 50 years. The annual Healthcare Conference is an informational service and networking opportunity for healthcare companies and investors. Nearly 300 other public and private healthcare and pharmaceutical companies will be presenting at the financial conference. For more information, visit www.rodmanandrenshaw.com.
DOBI Medical is a developmental stage, medical imaging company working to create a new means for the improved diagnosis of breast disease through the identification of abnormal neovascularization ("angiogenesis") associated with tumors. DOBI Medical International's first application of the technology is the ComfortScan system, a gentle, noninvasive, and nonionizing, optical imaging system designed as an adjunct to mammography to assist physicians in the identification and management of breast disease. The ComfortScan system is intended to achieve this by providing new, physiology-based imaging of abnormal vascularization in the breast that is not readily available today. The ComfortScan system has CE Mark and UL certifications. DOBI Medical is a certified ISO 9001:2000 and ISO 13485:2003 company. The Company currently sells its ComfortScan systems to international distributors for installation at international clinical trial sites. The ComfortScan system is not being sold in the U.S. as it is limited by U.S. law to investigational use until approved by the FDA, which cannot be guaranteed. For more information on DOBI Medical International or the ComfortScan system, visit www.dobimedical.com.
